Chloroquine Analogues as Leads against Pneumocystis Lung Pathogens

Gomes, Ana; Ferraz, Ricardo; Ficker, Lauren; Collins, Margaret S.; Prudêncio, Cristina; Cushion, Melanie T.; Teixeira, Cátia; Gomes, Paula

http://hdl.handle.net/10400.22/14183

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
ART_RicardoFerraz_2018.pdf		1.22 MB	Adobe PDF	Download

Send Feedback

Authors

Abstract(s)

The impact of Pneumocystis pneumonia (PcP) on morbidity and mortality remains substantial for immunocompromised individuals, including those afflicted by HIV infection, organ transplantation, cancer, autoimmune diseases, or subject to chemotherapy or corticosteroid-based therapies. Previous work from our group has shown that repurposing antimalarial compounds for PcP holds promise for treatment of this opportunistic infection. Following our previous discovery of chloroquine analogues with dual-stage antimalarial action both in vitro and in vivo, we now report the potent action of these compounds on Pneumocystis carinii in vitro Identification of chloroquine analogues as anti-PcP leads is an unprecedented finding.

Keywords

Pneumocystis chloroquine Immunosuppressed Lung infection Malaria Pneumonia

URI

http://hdl.handle.net/10400.22/14183

Citation

Gomes, A., Ferraz, R., Ficker, L., Collins, M. S., Prudêncio, C., Cushion, M. T., Teixeira, C., & Gomes, P. (2018). Chloroquine Analogues as Leads against Pneumocystis Lung Pathogens. Antimicrobial Agents and Chemotherapy, 62(11), 10.1128/aac.00983-18. https://doi.org/10.1128/aac.00983-18